Diverse perspectives on science and medicine
Reshma Ramachandran and David Carroll warn that the Trans-Pacific Partnership will trample over access to affordable medicines Last month, Wikileaks posted the complete Intellectual Property (IP) Chapter of the secretly-negotiated Trans-Pacific Partnership Agreement (TPP) confirming
Heather Wipfli, from the University of Southern California, highlights the lack of consensus regarding the role of private industry in efforts to control the burden of non-communicable diseases. Non-communicable diseases (NCDs) were extensively discussed at
This week PLOS Medicine publishes the following new articles: Physical inactivity is the fourth leading global risk factor for death, and also a major cause of non-communicable diseases (chronic diseases such as heart disease and
Kristine Husøy Onarheim and Johanne Helene Iversen from Universities Allied for Essential Medicines write about the broken system for drug development, and how governments are given an opportunity to address it. The member states of
Isobel Braithwaite shares her thoughts on the recent launch event of the Turning the World Upside Down online platform. A couple of weeks back, I attended the launch event of the new Turning the World
Síle Lane from Sense About Science discusses the recent European Court injunction on clinical trial data. The European General Court has issued an injunction to prevent the European medicines regulator from releasing information from clinical
In a Policy Forum article published in this week’s PLOS Medicine Jim McCambridge and colleagues analyze submissions made by Alcohol Industry actors to the Scottish Government’s 2008 consultation on ‘Changing Scotland’s relationship with alcohol.’ The
A new initiative to bring to the forefront the issue of trial registration has just been launched, led by Ben Goldacre (who runs the Bad Science website and who is the author of Bad Science
Ruby Singhrao reports from last month’s TEDx San Franicsco conference, dedicated to advances in global health. On November 10th 2012, the University of California San Francisco (UCSF) hosted a TEDx conference on global health. The
Carl Heneghan, Director of the University of Oxford’s Centre of Evidence-Based Medicine, discusses recent developments in access to clinical-trial data. The Pharmaceutical industry and drug regulators treat clinical data, submitted at the time of regulation,